Table 1.
m6A-related lncRNAs signatures.
| Malignancies | m6A-related lncRNA signature | References |
|---|---|---|
| Breast cancer (TCGA-BRCA) (Adenomas and Adenocarcinomas, Adnexal and Skin Appendage Neoplasms, Basal Cell Neoplasms, Complex Epithelial Neoplasms, Cystic, Mucinous and Serous Neoplasms, Ductal and Lobular Neoplasms, Epithelial Neoplasms, NOS, Fibroepithelial Neoplasms, Squamous Cell Neoplasms) | AL359076.1, MFF-DT, AC114947.2, MIATNB, FARP1-AS1, AC106028.2, U73166.1, AP000919.3, ZNF197-AS1, AP005131.2, SP2-AS1,AL592301.1, OTUD6B-AS1, AL138789.1, COL4A2-AS1, AC024145.1, AL513218.1, LRRC8C-DT, AL021707.4, MIR302CHG, AC012442.2 | (56) |
| Breast cancer (TCGA-BRCA) | Z68871.1, AL122010.1, OTUD6B-AS1, AC090948.3, AL138724.1, EGOT | (57) |
| Osteosarcoma (TARGET-OS) (osseous and chondromatous neoplasms) | AP003119.2, LINC01816, AL139289.1, AC004812.2, AC005785.1, AL353804.1 | (58) |
| Gastric cancer (TCGA-STAD) (Adenomas and Adenocarcinomas, Cystic, Mucinous and Serous Neoplasms) | AL049840.3, AC008770.3, AL355312.3, AC108693.2, BACE1-AS, AP001528.1, AP001033.2, AC092574.1, AC010719.1, AC009090.3, SAMD12-AS1 | (59) |
| Glioma (TCGA-GBM) and (TCGA-LGG) | AL390755.1, AL445524.1, AL359643.3, LINC00641, AL117332.1, LNCTAM34A, CRNDE, AP001486.2, CARD8. AS1 | (60) |
| Pancreatic ductal adenocarcinoma (TCGA-PDAC) | AP005233.2, AC092171.3, AC010175.1, CASC8, TP53TG1, SNAI3.AS1, FLRT1, AC022098.1, DCST1.AS1 | (61) |
| Clear-Cell Renal Cell Carcinoma (ccRCC) (TCGA-KIRC) | AC009948.2, AC011752.1, AC018752.1, AF117829.1, AL008718.3, AL133243.3, AL158071.5, COL18A1-AS1, DLEU2, LINC00115, RPL34-AS1, SNHG10 | (62) |
| Lung Squamous Cell Carcinoma (TCGA-LUSC) | AL122125.1, HORMAD2-AS1 | (63) |
| Lung Adenocarcinoma (TCGA-LUAD) (Acinar Cell Neoplasms, Adenomas and Adenocarcinomas, Cystic, Mucinous and Serous Neoplasms) | ADPGK-AS1, AC103591.3, AC018529.1, AC010175.1, AC016747.2, AC007613.1, AC026355.2, ABALON, AC034102.8, AC073316.3, AL031667.3, AC005884.1, TSPOAP1-AS1 | (64) |
| Lung Adenocarcinoma (TCGA-LUAD) (Acinar Cell Neoplasms, Adenomas and Adenocarcinomas, Cystic, Mucinous and Serous Neoplasms) | TMPO-AS1, OGFRP1, LINC01117, HIF1A-AS1, LINC00592, WWC2-AS2, TARID, LINC00628, ABCA9-AS1 | (65) |
| Ovarian cancer (TCGA-OV) (Cystic, Mucinous and Serous Neoplasms) | WACAS1, TRAM2-AS1, SH3RF3-AS1, PCOLCE-AS1, MYCNOS, LINC01270, LINC00592, LAMTOR5-AS1, FOXN3-AS1, DLGAP1-AS2, DICER1-AS1, ARHGAP26-AS1 | (66) |
| Ovarian cancer (TCGA-OV) (Cystic, Mucinous and Serous Neoplasms) | AC008669.1, AC010336.1, AC097376.3, AC130710.1, ACAP2-IT1, AL138820.1, CACNA1G-AS1 | (67) |
| Ovarian cancer (TCGA-OV) (Cystic, Mucinous and Serous Neoplasms) | DNM3OS,WAC-AS1, FOXNS-AS1, LINC00997 | (28) |
| Bladder (TCGA-BLCA) (Adenomas and Adenocarcinomas, Epithelial Neoplasms, NOS, Squamous Cell Neoplasms,Transitional Cell Papillomas and Carcinomas) | PTOV1-AS2, AC116914.2, EHMT2-AS1, AC004148.1, AL136295.2,KCNQ1OT1, AC104564.3, AC073534.2, ATP1B3-AS1 | (68) |
| Bladder (TCGA-BLCA) (Adenomas and Adenocarcinomas, Epithelial Neoplasms, NOS, Squamous Cell Neoplasms,Transitional Cell Papillomas and Carcinomas) | AC006160.1, AC004076.2, BDNF-AS, AC073575.4, AC097641.2, MAP3K14-AS1, ZNF32-AS2, AL136295.2, ZFN436-AS1, AC025280.1, SNHG16, ATP1B3-AS1, AP001469.1, AC005479.1 | (69) |
| Acute myeloid Leukemia (TCGA-LAML) | FAM30A, HCP5, LINC00963,TMEM147-AS1,TTTY15, LINC00342, MEG3, HCG18, N4BP2L2-IT2 | (70) |
| Hepatocellular carcinoma (TCGA-LIHC) (Adenomas and Adenocarcinomas) | ZEB1-AS1, MIR210HG, BACE1-AS, SNHG3 | (71) |
| Hepatocellular carcinoma (TCGA-LIHC) (Adenomas and Adenocarcinomas) | AP001469.3, AL031985.3, SREBF2-AS1, AL442125.2,MKLN1-AS, AL590705.3, TMCC1-AS1, NRAV, C2orf27A, POLH-AS1, AL158166.1, LINC01138, WAC-AS1, AL117336.2 | (72) |
| Colon adenocarcinoma (TCGA-COAD) (Adenomas and Adenocarcinomas, Complex Epithelial Neoplasms, Cystic, Mucinous and Serous Neoplasms, Epithelial Neoplasms, NOS) | AC027307.2, MIR200CHG, RHOA-IT1, AC009996.1, AL138831.2, AC010168.2, AC007066.2, AC019118.1, ALMS1-IT1, UBA6-AS1, SNHG16, FENDRR, RAMP2-AS1, AC013652.1 | (73) |